Cite
Biliverdin Reductase B Is a Plasma Biomarker for Intraplaque Hemorrhage and a Predictor of Ischemic Stroke in Patients with Symptomatic Carotid Atherosclerosis.
MLA
Chemaly, Melody, et al. “Biliverdin Reductase B Is a Plasma Biomarker for Intraplaque Hemorrhage and a Predictor of Ischemic Stroke in Patients with Symptomatic Carotid Atherosclerosis.” Biomolecules (2218-273X), vol. 13, no. 6, June 2023, p. 882. EBSCOhost, https://doi.org/10.3390/biom13060882.
APA
Chemaly, M., Marlevi, D., Iglesias, M.-J., Lengquist, M., Kronqvist, M., Bos, D., van Dam-Nolen, D. H. K., van der Kolk, A., Hendrikse, J., Kassem, M., Matic, L., Odeberg, J., de Vries, M. R., Kooi, M. E., & Hedin, U. (2023). Biliverdin Reductase B Is a Plasma Biomarker for Intraplaque Hemorrhage and a Predictor of Ischemic Stroke in Patients with Symptomatic Carotid Atherosclerosis. Biomolecules (2218-273X), 13(6), 882. https://doi.org/10.3390/biom13060882
Chicago
Chemaly, Melody, David Marlevi, Maria-Jesus Iglesias, Mariette Lengquist, Malin Kronqvist, Daniel Bos, Dianne H. K. van Dam-Nolen, et al. 2023. “Biliverdin Reductase B Is a Plasma Biomarker for Intraplaque Hemorrhage and a Predictor of Ischemic Stroke in Patients with Symptomatic Carotid Atherosclerosis.” Biomolecules (2218-273X) 13 (6): 882. doi:10.3390/biom13060882.